Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Collichio

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Dermatopathology|April 4, 2024
Lymphangitic Melanomatosis: Case Report of Intralymphatic Spread of Melanoma in a 66-year-old ManShantanu Srivatsa, Collin-Jamal Smith, Omar P Sangüeza, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 4, 2023
Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and ActionJacob N Stein, Jacquelyne J Gaddy, Jonathan D Sorah, et al.
BMC Palliative Care|March 11, 2021
How well do documented goals-of-care discussions for patients with stage IV cancer reflect communication best practices?Natalie C Ernecoff, Kathryn L Wessell, William A Wood, et al.
Oncology|December 4, 2019
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution ExperienceGeorgia Sofia Karachaliou, Fatih Ayvali, Frances A Collichio, et al.
Journal for Immunotherapy of Cancer|September 20, 2017
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trialsHoward L Kaufman, Robert H I Andtbacka, Frances A Collichio, et al.
Journal for Immunotherapy of Cancer|January 10, 2019
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-seriesAbdul Rafeh Naqash, Danielle M File, Carolyn M Ziemer, et al.
Annals of Surgical Oncology|July 3, 2026
ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma PatientsKristen E Dougherty, Gray B Peery, Ananya Saravanan, et al.
Journal of Computer Assisted Tomography|September 17, 2016
Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and MelanomaAna Marija Franceschi, Stergios J Moschos, Carey K Anders, et al.
Annals of Surgical Oncology|June 26, 2026
Implementing Paradigm Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma PatientsKristen E Dougherty, Gray B Peery, Ananya Saravanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Developing an in-training examination for fellows: the experience of the American Society of Clinical OncologyFrances A Collichio, Karen M Kayoumi, Kenneth R Hande, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Dermatopathology|April 4, 2024
Lymphangitic Melanomatosis: Case Report of Intralymphatic Spread of Melanoma in a 66-year-old ManShantanu Srivatsa, Collin-Jamal Smith, Omar P Sangüeza, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 4, 2023
Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and ActionJacob N Stein, Jacquelyne J Gaddy, Jonathan D Sorah, et al.
BMC Palliative Care|March 11, 2021
How well do documented goals-of-care discussions for patients with stage IV cancer reflect communication best practices?Natalie C Ernecoff, Kathryn L Wessell, William A Wood, et al.
Oncology|December 4, 2019
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution ExperienceGeorgia Sofia Karachaliou, Fatih Ayvali, Frances A Collichio, et al.
Journal for Immunotherapy of Cancer|September 20, 2017
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trialsHoward L Kaufman, Robert H I Andtbacka, Frances A Collichio, et al.
Journal for Immunotherapy of Cancer|January 10, 2019
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-seriesAbdul Rafeh Naqash, Danielle M File, Carolyn M Ziemer, et al.
Annals of Surgical Oncology|July 3, 2026
ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma PatientsKristen E Dougherty, Gray B Peery, Ananya Saravanan, et al.
Journal of Computer Assisted Tomography|September 17, 2016
Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and MelanomaAna Marija Franceschi, Stergios J Moschos, Carey K Anders, et al.
Annals of Surgical Oncology|June 26, 2026
Implementing Paradigm Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma PatientsKristen E Dougherty, Gray B Peery, Ananya Saravanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Developing an in-training examination for fellows: the experience of the American Society of Clinical OncologyFrances A Collichio, Karen M Kayoumi, Kenneth R Hande, et al.
Pageof 5